Clinical trial
Reasons for Changing HOrmonal Therapy of Advanced Breast Cancer
NCT01265654 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Reasons for Changing HOrmonal Therapy of Advanced Breast Cancer
- Lead sponsor
- AstraZeneca
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2011
- Completion date
- November 30, 2011
- Enrollment
- 234 (actual)
- Sites
- 37
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer